Dna X (SONM) Other Non-Current Liabilities (2018 - 2026)

Dna X's Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $398000.0 for Q1 2026.

• Quarterly Other Non-Current Liabilities fell 77.81% year-over-year to $398000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $398000.0 (down 77.81% YoY) and the FY2025 annual result came in at $171000.0, down 89.94% from the prior year.
• Other Non-Current Liabilities was $398000.0 for Q1 2026 at Dna X, up from $171000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $1.8 million in Q3 2025 and bottomed at $171000.0 in Q4 2025.
• A 5-year average of $1.4 million and a median of $1.5 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Peak annual rise in Other Non-Current Liabilities reached 16.12% in 2025, while the deepest fall reached 89.94% in 2025.
• Dna X's Other Non-Current Liabilities stood at $1.4 million in 2022, then climbed by 6.93% to $1.5 million in 2023, then advanced by 11.19% to $1.7 million in 2024, then sank by 89.94% to $171000.0 in 2025, then soared by 132.75% to $398000.0 in 2026.
• Business Quant data shows SONM's Other Non-Current Liabilities at $398000.0 in Q1 2026, $171000.0 in Q4 2025, and $1.8 million in Q3 2025.